Ponzone A, Guardamagna O, Spada M, Ferraris S, Ponzone R, Kierat L, Blau N
Department of Paediatrics, University of Sassari, Italy.
Eur J Pediatr. 1993 Aug;152(8):655-61. doi: 10.1007/BF01955242.
We describe a new fully reliable method for the differential diagnosis of tetrahydrobiopterin-dependent hyperphenylalaninaemia (HPA). The method comprises the combined phenylalanine (Phe) plus tetrahydrobiopterin (BH4) oral loading test and enables the selective screening of BH4 deficiency when pterin analysis is not available or when a clear diagnosis has not been previously made. It should be performed together with the measurement of dihydropteridine reductase (DHPR) activity in blood. The new combined loading test was performed in nine patients with primary HPA, three with classical phenylketonuria (PKU), three with DHPR deficiency, and three with 6-pyruvoyl tetrahydropterin synthase (PTPS) deficiency. Three hours after oral Phe loading (100 mg/kg body weight), synthetic BH4 was administered orally at doses of either 7.5 or 20 mg/kg body weight. Amino acid (Phe and tyrosine) and pterin (neopterin and biopterin) metabolism and kinetics were analysed. By exploiting the decrease in serum Phe 4 and 8 h after administration, a clear response was obtained with the higher BH4 dose (20 mg/kg body weight), allowing detection of all cases of BH4 deficiency, as well as differentiation of BH4 synthesis from regeneration defects. Since DHPR deficient patients who were previously shown to be non-responsive to the simple BH4 loading test gave a positive response, the combined Phe plus BH4 loading test can be used as a more reliable tool for the differential diagnosis of HPA in these patients. Moreover, it takes advantage of being performed while patients are on a Phe-restricted diet.
我们描述了一种用于鉴别诊断四氢生物蝶呤依赖性高苯丙氨酸血症(HPA)的全新完全可靠的方法。该方法包括联合苯丙氨酸(Phe)加四氢生物蝶呤(BH4)口服负荷试验,当无法进行蝶呤分析或之前未明确诊断时,可用于选择性筛查BH4缺乏症。该试验应与血液中二氢蝶啶还原酶(DHPR)活性的测定同时进行。对9例原发性HPA患者、3例经典苯丙酮尿症(PKU)患者、3例DHPR缺乏症患者和3例6-丙酮酰四氢蝶呤合酶(PTPS)缺乏症患者进行了新的联合负荷试验。口服苯丙氨酸(100 mg/kg体重)3小时后,以7.5或20 mg/kg体重的剂量口服给予合成BH4。分析了氨基酸(苯丙氨酸和酪氨酸)以及蝶呤(新蝶呤和生物蝶呤)的代谢和动力学。通过利用给药后4小时和8小时血清苯丙氨酸的下降情况,较高剂量的BH4(20 mg/kg体重)获得了明确的反应,能够检测出所有BH4缺乏症病例,并区分BH4合成缺陷与再生缺陷。由于之前显示对简单BH4负荷试验无反应的DHPR缺乏症患者出现了阳性反应,因此联合苯丙氨酸加BH4负荷试验可作为这些患者HPA鉴别诊断更可靠的工具。此外,该试验利用了患者在限制苯丙氨酸饮食期间进行的优势。